跳至主要内容
临床试验/NCT00003931
NCT00003931已完成不适用

Assessment of the Partial Tandem Duplication of ALL1 (MLL) in Patients With Acute Myeloid Leukemia- A CALGB Leukemia Tissue Bank Project

Alliance for Clinical Trials in Oncology46 个研究点 分布在 1 个国家目标入组 9,769 人开始时间: 1999年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9,769
试验地点
46
主要终点
frequency of partial tandem duplication of ALL1 (MLL)

研究概览

简要总结

RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute myeloid leukemia and determine the extent of disease.

PURPOSE: Diagnostic study to try to detect changes in the genes of patients who have acute myeloid leukemia.

详细描述

OBJECTIVES:

  • Determine the frequency of partial tandem duplication of ALL1 (MLL) in patients with acute myeloid leukemia (AML).
  • Determine the predictive value of partial tandem duplication of ALL1 to identify a subset of AML patients who have a short duration of complete remission.

OUTLINE: All samples are obtained from specimens collected on CALGB-9665. No additional blood or bone marrow samples are collected.

Samples are examined by Southern blot analysis for gene rearrangement at 11q23. Samples showing evidence of ALL1 gene rearrangement are further analyzed by reverse transcription PCR amplification and/or cytogenetic analysis to detect partial tandem duplication of ALL1.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

frequency of partial tandem duplication of ALL1 (MLL)

时间窗: Up to 10 years

次要结局

  • predictive value of partial tandem duplication of ALL1(Up to 10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (46)

Loading locations...

相似试验